DARPA launched its “Quantum Benchmarking Initiative,” aiming to chart a path toward an industrially viable quantum computer ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

A government initiative is developing advanced alternative testing methods that use no animals in the pharmaceutical ...

As the head of HHS, Kennedy said his federal department is undergoing an “AI revolution.” He implored viewers to “stop ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Automation and artificial intelligence are streamlining everything from regulatory tasks to clinical trials and drug ...

SandboxAQ, an artificial intelligence startup backed by Nvidia NVDA +0.48% Get Free Report and born from Alphabet's GOOG ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...